• Investing
  • Stock
  • Economy
  • Editor’s Pick
Bald Eagle Traders
Investing, Stock, Economy News

The Shift in Our Creative Toolkit: 5 AI Tools to Explore in...

February 24, 2026 0 comment

How three Chinese AI firms ran industrial-scale free ride on Claude

February 23, 2026 0 comment

Why is Palantir stock down 37% from its peak: is worst over...

February 23, 2026 0 comment

Citrini’s ‘thought exercise’ on AI sparks selloff in Visa, DoorDash, others

February 23, 2026 0 comment

PayPal attracts unsolicited takeover interest: who might be mystery buyer?

February 23, 2026 0 comment

SoFi stock price has imploded: will it rebound?

February 23, 2026 0 comment
  • Stock

  • Investing

  • Editor's Pick

Investing

Markets: Investment Insights on Braving the Bear

by January 9, 2023

Each quarter, our investment team comments on the markets and economy over the past quarter and looks forward at what…

by January 9, 2023

How To Calculate Your Retirement Number

January 4, 2023
by January 4, 2023

4 fast money lessons from our Tesla winners

December 23, 2022
by December 23, 2022

Can You Inherit Debt?

December 13, 2022
by December 13, 2022

How much could your student loan payment be if student loan forgiveness goes into effect? Use this calculator to find out

December 7, 2022
by December 7, 2022

Stock

How three Chinese AI firms ran industrial-scale free ride on Claude

by February 23, 2026

Anthropic says it has uncovered what amounts to an industrial-scale “free ride” on one of America’s best AI models. In…

by February 23, 2026

Why is Palantir stock down 37% from its peak: is worst over for PLTR?

February 23, 2026
by February 23, 2026

Citrini’s ‘thought exercise’ on AI sparks selloff in Visa, DoorDash, others

February 23, 2026
by February 23, 2026

PayPal attracts unsolicited takeover interest: who might be mystery buyer?

February 23, 2026
by February 23, 2026

SoFi stock price has imploded: will it rebound?

February 23, 2026
by February 23, 2026
  • Stock

    Vanda stock’s explosive rally may be more hype than substance

    by February 23, 2026
    by February 23, 2026

    Vanda Pharmaceuticals (NASDAQ: VNDA) opened some 45% higher today after the biotech firm said it has received the FDA’s approval…

  • Stock

    Why is Nvidia stock soaring before Q4 earnings? Here’s $65.9B reason

    by February 23, 2026
    by February 23, 2026

    Nvidia stock (NASDAQ: NVDA) ticked higher on Monday as Wall Street headed into the chipmaker’s Feb. 25 earnings report with…

  • Stock

    Why Tesla stock is down over 2% on Monday

    by February 23, 2026
    by February 23, 2026

    Tesla stock declined at the start of the new trading week, as investors assessed intensifying competition in autonomous driving and…

  • Economy

    Moralizing Markets: Vatican Bank Wades into Faith-Based Indexing

    by February 23, 2026
    by February 23, 2026

    Markets have long been accused of lacking morality. On February 10, the Vatican decided to supply one. The Institute for…

  • Stock

    We predicted Blue Owl stock price crash: what’s next?

    by February 23, 2026
    by February 23, 2026

    Blue Owl stock price has crashed in the past few months, turning one of the most blue-chip financial giants into…

  • Stock

    Merck creates separate oncology arm ahead of Keytruda patent loss

    by February 23, 2026
    by February 23, 2026

    Merck said on Monday that it will split its human-health operations into two separate divisions, a move designed to sharpen…

  • Stock

    Royal Bank of Canada stock double-tops ahead of Q1 earnings

    by February 23, 2026
    by February 23, 2026

    Royal Bank of Canada stock has been in an unstoppable bull run in the past few years and is now…

  • Stock

    Eli Lilly bets on multi-dose Zepbound pen in GLP-1 retention push

    by February 23, 2026
    by February 23, 2026

    Millions of people on GLP-1 weight-loss drugs know the weekly routine by heart: a new injector pen, a new box,…

  • Stock

    US stocks open flat after Trump raises global tariffs to 15%

    by February 23, 2026
    by February 23, 2026

    US equities were little changed on Monday after President Donald Trump announced an increase in global tariffs to 15%, following…

  • Stock

    Almirall profit quadruples in 2025 as dermatology fuels growth push

    by February 23, 2026
    by February 23, 2026

    Almirall, a pharmaceutical firm based in Spain, ended 2025 with a net profit of €46.2 million, which was 357% more…

Newer Posts
Older Posts

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • The Shift in Our Creative Toolkit: 5 AI Tools to Explore in 2026
    • How three Chinese AI firms ran industrial-scale free ride on Claude
    • Why is Palantir stock down 37% from its peak: is worst over for PLTR?
    • Citrini’s ‘thought exercise’ on AI sparks selloff in Visa, DoorDash, others
    • PayPal attracts unsolicited takeover interest: who might be mystery buyer?

    Popular Posts

    • 1

      How To Calculate Your Retirement Number

      January 4, 2023
    • 2

      Markets: Investment Insights on Braving the Bear

      January 9, 2023
    • 3

      Can You Inherit Debt?

      December 13, 2022

    Categories

    • Economy (66)
    • Editor's Pick (36)
    • Investing (20)
    • Stock (227)

    Disclaimer: BaldEagleTraders.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 baldeagletraders.com | All Rights Reserved

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Back To Top
    Bald Eagle Traders
    • Investing
    • Stock
    • Economy
    • Editor’s Pick